What to do with HLA-DO?

Immunogenetics

Volumn 51, Issue 10, 2000, Pages 765-770

  Van Ham, Marieke ^a   Van Lith, Marcel ^a   Griekspoor, Alexander ^a   Neefjes, Jacques ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Autoimmunity; B lymphocytes; HLA DM; HLA DO; MHC class II antigen presentation

Indexed keywords

AMINO ACID; HLA DM ANTIGEN; HLA DO ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; ENDOCYTOSIS; GENE; GENE EXPRESSION; HUMAN; LYSOSOME; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW; SEQUENCE HOMOLOGY;

ANIMALS; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HUMANS; PEPTIDES;

EID: 0033855183     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510000208     Document Type: Review

References (49)

1. Agnes MC, Tan A, Jordens R, Geluk A, Roep BO, Ottenhoff T, Drijfhout JW, Koning F (1998) Strongly increased efficiency of altered peptide ligands by mannosylation. Int Immunol 10:1299-1304
2. Arndt SO, Vogt AB, Markovic-Plese S, Martin R, Moldenhauer G, Wolpl A, Sun Y, Schadendorf D, Hammerling GJ, Kropshofer H (2000) Functional HLA-DM on the surface of B cells and immature dendritic cells. EMBO J 2000 19:1241-1251
3. Avva RR, Cresswell P (1994) In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763-774
4. Bakke O, Dobberstein B (1990) MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707-716
5. Chang CH, Guerder S, Hong SC, Ewijk W van, Flavell RA (1996) Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167-178
6. + T cell priming in vivo. J Immunol 162:5695-5703
7. Daeron M (1997) Fc receptor biology. Annu Rev Immunol 15:203-234
8. Denzin LK, Cresswell P (1995) HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155-165
9. Denzin LK, Hammond C, Cresswell P (1996) HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 184:2153-2165
10. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P (1997) Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278:106-109
11. Fremont DH, Crawford F, Marrack P, Hendrickson WA, Kappler J (1998) Crystal structure of mouse H2-M. Immunity 9:385-393
12. Gapin L, Bravo de Alba Y, Casrouge A, Cabaniols JP, Kourilsky P, Kanellopoulos J (1998) Antigen presentation by dendritic cells focuses T cell responses against immunodominant peptides: studies in the hen egg-white lysozyme (HEL) model. J Immunol 160:1555-1564
13. Ghosh P, Amaya M, Mellins E, Wiley DC (1995) The structure of an intermediate in MHC maturation: CLIP bound to HLA-DR3. Nature 378:457-462
14. Griffin JP, Chu R, Harding CV (1997) Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J Immunol 158:1523-1532
15. Ham SM van, Grüneberg U, Malcherek G, Bröker I, Melms A, Trowsdale J (1996) Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J Exp Med 184:2019-2024
16. Ham SM van, Tjin EPM, Lillemeier BF, Grüneberg U, Meijgaarden KE van, Pastoors L, Verwoerd D, Tulp A, Canas B, Rahman D, Ottenhoff THM, Pappin DJC, Trowsdale J. Neefjes J (1997) HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 7:950-957
17. Ham M van, Lith M van, Lillemeier B, Tjin E, Grüneberg U, Rahman D, Pastoors L, Meijgaarden K van, Roucard C, Trowsdale J, Ottenhoff T, Pappin D, Neefjes J (2000) Modulation of the MHC class II-associated peptide repertoire by HLA-DO. J Exp Med 191:1127-1135
18. Kelly AP, Monaco JJ, Cho SG, Trowsdale J (1991) A new human HLA class II-related locus, DM. Nature 353:571-573
19. Kropshofer H, Vogt AB, Moldenhauer GJH, Blum JS, Hämmerling GJ (1996) Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J 15:6144-6154
20. Kropshofer H, Arndt SO, Moldenhauer G, Hammerling GJ, Vogt AB (1997) HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6:293-302
21. Kropshofer H, Vogt AB, Thery C, Armandola EA, Li BC, Moldenhauer G, Amigorena S, Hammerling GJ (1998) A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 17:2971-81
22. Liljedahl M, Kuwana T, Fung-Leung WP, Jackson MR, Peterson PA, Karlsson L (1996) HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 15:4817-4824
23. Liljedahl M, Winqvist O, Surh CD, Wong P, Ngo K, Teyton L, Peterson PA, Brunmark A, Rudensky AY, Fung-Leung WP, Karlsson L (1998) Altered antigen presentation in mice lacking H2-O. Immunity 8:233-243
24. Long EO, LaVaute T, Pinet V, Jaraquemada D (1994) Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide. J Immunol 153:1487-1494
25. Mach B (1999) Perspectives: immunology. Regulating the regulator. Science 285:1367
26. Mitchell RN, Barnes KA, Grupp SA, Sanchez E, Misulovin Z, Nussenzweig MC, Abbas AK (1995) Intracellular targeting of antigens internalized by membrane immunoglobulin in B lymphocytes. J Exp Med 181:1705-1714
27. Mosyak L, Zaller DM, Wiley DC (1998) The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9:377-383
28. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY (1998) Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280:450-453
29. Neefjes JJ, Stollorz V, Peters PJ, Geuze HJ, Ploegh HL (1990) The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61:171-183
30. Page RD (1996) TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci 12:357-358
31. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze, HJ (1991) Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669-676
32. Pinet VM, Long EO (1998) Peptide loading onto recycling HLA-DR molecules occurs in early endosomes. Eur J Immunol 28:799-804
33. Riese RJ, Wolf PR, Bromme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA (1996) Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4:357-366
34. Romagnoli P, Germain RN (1994) The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J Exp Med 180:1107-1113
35. Sanderson F, Powis SH, Kelly AP, Trowsdale J (1994a) Limited polymorphism in HLA-DM does not involve the peptide binding groove. Immunogenetics 39:56-58
36. Sanderson F, Kleijmeer MJ, Kelly AP, Verwoerd D, Tulp A, Neefjes JJ, Geuze HJ, Trowsdale J (1994b) Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science 266:1566-1569
37. Sanderson F, Thomas C, Neefjes J, Trowsdale J (1996) Association between HLA-DM and HLA-DR in vivo. Immunity 4:87-96
38. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM (1998) B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 161:3912-3918
39. Sherman MA, Weber DA, Jensen PE (1995) DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197-205
40. Siemasko K, Eisfelder BJ, Williamson E, Kabak S, Clark MR (1998). Signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. J Immunol 160:5203-5208
41. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM (1995) Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802-806
42. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B (1994) Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106-109
43. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876-4882
44. Tonnelle C, DeMars R, Long EO (1985) DO beta: a new beta chain gene in HLA-D with a distinct regulation of expression. EMBO J 4:2839-2847
45. Ullrich HJ, Döring K, Grüneberg U, Jähnig F, Trowsdale J, Ham SM van (1997) Interaction between HLA-DM and HLA-DR involves regions that undergo conformational changes at lysosomal pH. Proc Natl Acad Sci USA 94:13163-13168
46. Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D (1993) Mice lacking the MHC class II-associated invariant chain. Cell 72:635-648
47. Weber DA, Evavold BD, Jensen PE (1996) Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618-620
48. Wubbolts R, Fernandez-Borja M, Oomen L, Verwoerd D, Janssen H, Calafat J, Tulp A, Dusseljee S, Neefjes J (1996) Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J Cell Biol 135:611-622
49. Young JA, Trowsdale J (1990) The HLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript. Immunogenetics 31:386-388